Back to results
US 2023/0054997 A1Published application
Copper complexes for treatment of neurodegenerative disorders
AssigneeALS Therapy Development Institute
InventorsMatvey Lukashev, Alexei Pushechnikov, Peter Demin, Kyle DENTON
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).
Claims42
A compound of Formula (V):
- or pharmaceutically acceptable salts thereof, wherein:
- R1 is C1-C6 alkyl optionally substituted with 5- to 10-membered heteroaryl, NH2, NH(C1-C6 alkyl), or N(C1-C6 alkyl)2;
- R2 is C1-C6 alkyl optionally substituted with 5- to 10-membered heteroaryl, NH2, NH(C1-C6 alkyl), or N(C1-C6 alkyl)2;
- R3 is 4- to 8-membered heterocycle or 5-membered heteroaryl, wherein the 4- to 8-membered heterocycle is optionally substituted one, two, or three times with the group R3a, and wherein the 5-membered heteroaryl is optionally substituted one, two, or three times with the group R3b;
- R3a independently for each occurrence is C1-C6 alkyl, C1-C6 alkyl-(C6-C10 aryl), C1-C6 alkyl-(5- to 10-membered heteroaryl), S(O)2H, S(O)2—(C1-C6 alkyl), S(O)2—(C3-C7 cycloalkyl), or S(O)2—(C6-C10 aryl);
- wherein each heteroaryl is optionally further substituted one to four times with C1-C6 alkyl or C6-C10 aryl;
- and wherein each C6-C10 aryl is optionally further substituted one to four times with C1-C6 alkyl;
- R3b independently for each occurrence is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 alkyl-N(R5)2, (C1-C6 alkyl)-O—(C1-C6 alkyl), halo, nitro, cyano, C6-C10 aryl, C(O)-(4- to 8-membered heterocycle), C1-C6 alkyl-(C6-C10 aryl), C1-C6 alkyl-(5- to 10-membered heteroaryl), or C1-C6 alkyl-(4- to 8-membered heterocycle), wherein each 4- to 8-membered heterocycle, C6-C10 aryl, and 5- to 10-membered heteroaryl are optionally further substituted one to four times with C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl, or halo;
- R4 is hydrogen or C1-3 alkyl;
- and
- R5 independently for each occurrence is hydrogen, C1-C6 alkyl, or C1-C3 alkyl-(C6-C10 aryl).
8 more elements
(canceled)
(canceled)
(canceled)
(canceled)
A compound of Formula (IV):
- or pharmaceutically acceptable salts thereof, wherein:
- L is C3-C7 cycloalkyl, C1-C6 alkyl, or absent;
- R1 is C1-C6 alkyl optionally substituted with 5- to 10-membered heteroaryl, NH2, NH(C1-C6 alkyl), or N(C1-C6 alkyl)2;
- R2 is C1-C6 alkyl optionally substituted with 5- to 10-membered heteroaryl, NH2, NH(C1-C6 alkyl), or N(C1-C6 alkyl)2;
- R3 is C6-C10 aryl, 5- to 10-membered heteroaryl, C3-C1 cycloalkyl, C(O)NH—(C1-C6 alkyl)-PPh3, hydroxy, C1-C6 alkoxy, or O—(C1-C6 alkyl)-O—(C1-C6 alkyl), wherein the C6-C10 aryl is substituted one, two, or three times with the group R3a, and wherein the 5- to 10-membered heteroaryl is optionally substituted one, two, or three times with the group R3b;
- R3a independently for each occurrence is C3-C7 cycloalkyl or 4- to 8-membered heterocycle, wherein the 4- to 8-membered heterocycle is optionally further substituted one, two, or three times with C1-C3 alkyl;
- R3b independently for each occurrence is C1-C3 alkyl, C1-C3 alkoxy, C3-C7 cycloalkyl, or 4- to 8-membered heterocycle, wherein the heterocycle is optionally further substituted one, two, or three times with C1-C3 alkyl;
- and
- R4 is hydrogen, C1-C3 alkyl, or C6-C10 aryl;
- provided that when L is absent, R3 is C6-C10 aryl substituted one, two, or three times with the group R3a;
- or when L is absent, R3 is 6- to 10-membered heteroaryl substituted one, two, or three times with the group R3b;
- or when L is absent, R3 is 6- to 10-membered heteroaryl optionally substituted one, two, or three times with the group R3b, and R4 is H.
9 more elements
(canceled)
(canceled)
26-36. (canceled)
38-47. (canceled)
A compound of Formula (III):
- or a pharmaceutically acceptable salt thereof, wherein:
- L is C1-C6 alkyl or absent
- R1 is C1-C6 alkyl optionally substituted with 5- to 10-membered heteroaryl, NH2, NH(C1-C6 alkyl), or N(C1-C6 alkyl)2;
- R2 is C1-C6 alkyl optionally substituted with 5- to 10-membered heteroaryl, NH2, NH(C1-C6 alkyl), or N(C1-C6 alkyl)2;
- R3 is C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, halo, hydroxy, C(O)NH2, C(O)NH(C1-C6 alkyl), C(O)N(C1-C6 alkyl)2, or C(O)-(4- to 8-membered heterocycle), wherein the C1-C6 alkyl and the C1-C6 alkoxy are optionally substituted one, two, or three times with C6-C10 aryl, and wherein the C(O)-(4- to 8-membered heterocycle) is optionally substituted one, two, or three times with C1-C3 alkyl.
2 more elements
49-54. (canceled)
56-58. (canceled)
62-68. (canceled)
A method of making a compound of Formula (I):
- or a pharmaceutically acceptable salt thereof, wherein:
- L is C3-C7 cycloalkyl, C1-C6 alkyl, or absent
- R1 is C1-C6 alkyl optionally substituted with 5- to 10-membered heteroaryl, NH2, NH(C1-C6 alkyl), or N(C1-C6 alkyl)2;
- R2 is C1-C6 alkyl optionally substituted with 5- to 10-membered heteroaryl, NH2, NH(C1-C6 alkyl), or N(C1-C6 alkyl)2;
- R3 is C6-C10 aryl, 5- to 10-membered heteroaryl, C(O)NH—(C1-C6 alkyl)-PPh3, hydroxy, C1-C6 alkoxy, or O—(C1-C6 alkyl)-O—(C1-C6 alkyl), wherein the C6-C10 aryl is substituted one, two, or three times with the group R3a, and wherein the 5- to 10-membered heteroaryl is optionally substituted one, two, or three times with the group R3b;
- R3a independently for each occurrence is C3-C7 cycloalkyl or 4- to 8-membered heterocycle, wherein the 4- to 8-membered heterocycle is optionally further substituted one, two, or three times with C1-C3 alkyl;
- R3b independently for each occurrence is C1-C3 alkoxy, C3-C7 cycloalkyl, or 4- to 8-membered heterocycle, wherein the heterocycle is optionally further substituted one, two, or three times with C1-C3 alkyl;
- and
- R4 is hydrogen, C1-C3 alkyl, or C6-C10 aryl;
- provided that when L is absent, R3 is C6-C10 aryl substituted one, two, or three times with the group R3a;
- or when L is absent, R3 is 6- to 10-membered heteroaryl substituted one, two, or three times with the group R3b;
- the method comprising mixing a compound of Formula (I-A):
- with a copper (II) salt to form the compound of Formula (I).
10 more elements
70-76. (canceled)
Dependencies are inferred from the claim text.